Comparison Between Base and Cover Slide From Endoscopic Ultrasound Guided Fine Needle Aspiration for Pancreatic Cancer

NCT ID: NCT02190071

Last Updated: 2016-05-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

73 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-06-30

Study Completion Date

2016-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether there is a difference of diagnostic accuracy between cover slides and base slides from EUS-FNA cytopathologic sample in patients who were previously suspected of pancreatic cancer in radiologic test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

1. background

1. Pancreatic cancer is the challenging malignancy in diagnosis and treatment.
2. Recently, EUS-FNA has played a important role in diagnosing pancreatic cancer.
3. Samples from EUS-FNA are sent to following three types of preparations.

* cytologic smear (by pull apart method)
* cell block
* histologic biopsy
4. In cytologic smear method, endoscopists tend to send as many as slides, while pathologists want minimal slides if they warrant diagnostic accuracy.
5. Therefore we are going to find a point of contact between high diagnostic yield and minimal overloading of pathologist.
2. Method

1. We are going to enrolled the patients who were suspected of pancreatic cancer in previous radiologic test.
2. One identical and skilled endoscopist performs EUS-FNA with multiple punctures.
3. We get total 8 pairs of slides (= 8 covers + 8 bases).
4. All the cover slides are collected to the bottle-A, all the base slide to the bottle-B.
5. One identical and skilled pathologist inspects these slide in blind method. (She cannot show the label of bottle so that she does not know what bottle is A or B.)
6. She record the positive or negative in each bottle. (If there is only one slide is positive in malignant cell, the bottle is positive.)
7. In these manner, we collect the all subjects' cytopathologic results as a pair of outcome. All the possible combinations are following four examples:

* (cover/base) = (positive/positive) = (+/+)
* (cover/base) = (positive/negative) = (+/-)
* (cover/base) = (negative/positive) = (-/+)
* (cover/base) = (negative/negative) = (-/-)
8. Then we are going to take a two-sided non-inferiority test of proportion using McNemar's test.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pancreatic Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients who were suspected of pancreatic cancer in previous radiologic test such as computed tomography, magnetic resonance imaging or Positron Emission Tomography.

Exclusion Criteria

* failed smear due to inexperienced assistant
* loss of slide
* patients who were diagnosed with other lesion far from pancreatic cancer in prospective confirmative tests.
* patients who refuse to participate in this study
* report of other pathologist who are not a previously-assigned pathologist
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Seoul National University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jaihwan Kim, M.D.

Role: STUDY_CHAIR

Seoul National University Bundang Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SNUBH-IMGPB-2014-03

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

25G and 22G Puncture Needles
NCT05101772 UNKNOWN